U.S. FDA Highlights Hands-On Approach To China Inspections In Budget Plan
This article was originally published in PharmAsia News
Executive Summary
The inspection focus of U.S. FDA’s budget request is largely on adding more personnel, but the agency continues to think about how best to target and leverage its resources in its globalization plan.